KFG Wealth Management LLC Purchases New Position in Stryker Corporation $SYK

KFG Wealth Management LLC purchased a new position in Stryker Corporation (NYSE:SYK) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 1,693 shares of the medical technology company’s stock, valued at approximately $595,000.

Several other large investors also recently added to or reduced their stakes in SYK. Clayton Financial Group LLC bought a new stake in shares of Stryker in the 3rd quarter valued at approximately $26,000. United Financial Planning Group LLC bought a new position in shares of Stryker during the 3rd quarter valued at approximately $27,000. Howard Hughes Medical Institute bought a new position in shares of Stryker during the 2nd quarter valued at approximately $29,000. Strive Asset Management LLC purchased a new stake in Stryker during the 3rd quarter valued at $30,000. Finally, ANTIPODES PARTNERS Ltd bought a new stake in Stryker in the third quarter worth $34,000. 77.09% of the stock is owned by institutional investors.

Stryker Stock Up 0.3%

Shares of SYK opened at $332.40 on Tuesday. The firm has a fifty day moving average price of $356.60 and a 200-day moving average price of $361.44. The company has a current ratio of 1.89, a quick ratio of 1.21 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $127.30 billion, a P/E ratio of 39.57, a P/E/G ratio of 1.94 and a beta of 0.92. Stryker Corporation has a 12-month low of $319.32 and a 12-month high of $404.87.

Stryker (NYSE:SYK) last issued its earnings results on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, topping analysts’ consensus estimates of $4.40 by $0.07. The business had revenue of $7.17 billion for the quarter, compared to the consensus estimate of $7.12 billion. Stryker had a net margin of 12.92% and a return on equity of 24.41%. The company’s revenue for the quarter was up 11.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $4.01 EPS. Equities research analysts expect that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. Stryker’s payout ratio is 41.90%.

Wall Street Analysts Forecast Growth

SYK has been the subject of several recent analyst reports. TD Cowen lowered shares of Stryker from a “buy” rating to a “hold” rating and set a $387.00 price objective for the company. in a research note on Monday, January 26th. Barclays restated an “overweight” rating and issued a $469.00 target price on shares of Stryker in a report on Monday, February 2nd. Raymond James Financial raised shares of Stryker from a “market perform” rating to an “outperform” rating and set a $418.00 price target for the company in a research note on Tuesday, January 6th. Piper Sandler reissued an “overweight” rating on shares of Stryker in a research report on Tuesday, January 27th. Finally, Citigroup reissued a “market outperform” rating on shares of Stryker in a research note on Friday, January 30th. Fourteen research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, Stryker presently has a consensus rating of “Moderate Buy” and a consensus price target of $427.50.

Insider Buying and Selling at Stryker

In other news, Director Ronda E. Stryker sold 250,000 shares of the stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the transaction, the director owned 2,457,331 shares of the company’s stock, valued at approximately $891,814,566.52. This represents a 9.23% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 5.90% of the company’s stock.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.